Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Data

The following table summarizes the unaudited quarterly financial data for the last two fiscal years:

 

CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share data and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2015

 

 

 

First Quarter

 

 

Second Quarter

 

 

Third Quarter

 

 

Fourth Quarter

 

Revenue

 

$

 

 

$

 

 

$

 

 

$

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

5,021

 

 

 

6,678

 

 

 

7,092

 

 

 

7,157

 

General and administrative

 

 

2,681

 

 

 

2,717

 

 

 

2,954

 

 

 

2,872

 

Total operating expenses

 

 

7,702

 

 

 

9,395

 

 

 

10,046

 

 

 

10,029

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

3

 

 

 

1

 

 

 

4

 

 

 

2

 

Interest expense

 

 

(721

)

 

 

(513

)

 

 

(509

)

 

 

(689

)

Total other income (expense) — net

 

 

(718

)

 

 

(512

)

 

 

(505

)

 

 

(687

)

Net loss attributable to common stockholders

 

$

(8,420

)

 

$

(9,907

)

 

$

(10,551

)

 

$

(10,716

)

Net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.41

)

 

$

(0.37

)

 

$

(0.39

)

 

$

(0.39

)

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

20,350,557

 

 

 

26,690,673

 

 

 

27,307,103

 

 

 

27,346,780

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2014

 

 

 

First Quarter

 

 

Second Quarter

 

 

Third Quarter

 

 

Fourth Quarter

 

Revenue

 

$

47

 

 

$

33

 

 

$

 

 

$

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

1,495

 

 

 

2,648

 

 

 

2,928

 

 

 

4,701

 

General and administrative

 

 

1,510

 

 

 

2,029

 

 

 

2,441

 

 

 

2,607

 

Total operating expenses

 

 

3,005

 

 

 

4,677

 

 

 

5,369

 

 

 

7,308

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

1

 

 

 

2

 

 

 

2

 

 

 

4

 

Interest expense

 

 

(461

)

 

 

(268

)

 

 

(191

)

 

 

(163

)

Loss on extinguishment of debt

 

 

 

 

 

(2,493

)

 

 

 

 

 

 

Decrease in value of preferred stock warrant liability

 

 

504

 

 

 

 

 

 

 

 

 

 

Total other income (expense) — net

 

 

44

 

 

 

(2,759

)

 

 

(189

)

 

 

(159

)

Net loss attributable to common stockholders

 

$

(2,914

)

 

$

(7,403

)

 

$

(5,558

)

 

$

(7,467

)

Net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(3.70

)

 

$

(0.44

)

 

$

(0.28

)

 

$

(0.37

)

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

786,986

 

 

 

16,883,716

 

 

 

20,124,574

 

 

 

20,125,009